Enzymatica AB (STU:EN9) FCF Yield %: -6.90 (As of Jul. 01, 2026)


STU:EN9 Enzymatica AB STU:EN9
57 GF Score
Price €0.19
GF Value €0.16
! 2 Warning Signs
View Full Analysis

What is Enzymatica AB FCF Yield %?

Enzymatica AB STU:EN9 -4.59% 57 FCF Yield % is -6.90 as of Jul. 01, 2026. GuruFocus rates STU:EN9 with a GF Score™ of 57/100 and a GF Value™ of €0.16. The stock has 2 warning signs investors should review. Among 1,003 Drug Manufacturers companies, Enzymatica AB ranks worse than 76.87% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Enzymatica AB's Trailing 12-Month Free Cash Flow is €-3.66 Mil, and Market Cap is €52.48 Mil. Therefore, Enzymatica AB's FCF Yield % for today is -6.90%.

The historical rank and industry rank for Enzymatica AB's FCF Yield % or its related term are showing as below:

STU:EN9' s FCF Yield % Range Over the Past 10 Years
Min: -36.44   Med: -8.81   Max: -0.14
Current: -6.9


During the past 13 years, the highest FCF Yield % of Enzymatica AB was -0.14%. The lowest was -36.44%. And the median was -8.81%.

STU:EN9's FCF Yield % is ranked worse than
76.87% of 1003 companies
in the Drug Manufacturers industry
Industry Median: 0.67 vs STU:EN9: -6.90

Enzymatica AB's FCF Margin % for the quarter that ended in Mar. 2026 was -59.70%.


Enzymatica AB FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Enzymatica AB FCF Yield % Related Terms


Enzymatica AB FCF Yield % Historical Data

* Premium members only.

The historical data trend for Enzymatica AB's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enzymatica AB FCF Yield % Chart

Enzymatica AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.31 -9.96 -6.64 -17.17 -9.28

Enzymatica AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.63 -13.78 -9.32 0.37 -4.02

STU:EN9 vs ZTS, UTHR: FCF Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Enzymatica AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzymatica AB FCF Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Enzymatica AB's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Enzymatica AB's FCF Yield % falls into.


STU:EN9
57GF Score
Enzymatica AB STU:EN9
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Enzymatica AB FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Enzymatica AB's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-3.786 / 40.77948
=-9.28%

Enzymatica AB's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.634 * 4 / 63.1111
=-4.02%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -6.90 mean?
Enzymatica AB (STU:EN9) has a FCF Yield % of -6.90 as of Jul. 01, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Enzymatica AB and its competitors. According to the industry distribution chart, Enzymatica AB ranks #771 out of 1003 companies in the Drug Manufacturers industry, placing it in the top 76.9%.
Is Enzymatica AB's FCF Yield % too high?
Enzymatica AB's current FCF Yield % is -6.90. Based on the distribution chart, Enzymatica AB ranks #771 out of 1003 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Enzymatica AB has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Enzymatica AB's FCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Enzymatica AB ranks #771 out of 1003 companies for FCF Yield %. This places Enzymatica AB in the lower half of its industry. The industry median FCF Yield % is 0.67. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.67, based on 1,003 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Enzymatica AB and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Enzymatica AB's current FCF Yield % is -6.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enzymatica AB stock overvalued right now?
Enzymatica AB (STU:EN9) has a current FCF Yield % of -6.90. The stock's GF Value™ is €0.16, compared to a current price of €0.19 — trading 16.9% above its estimated fair value. The current FCF Yield % is -6.90. Enzymatica AB's overall GF Score™ is 57/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Enzymatica AB (STU:EN9), the current FCF Yield % is -6.90 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Enzymatica AB (STU:EN9) Overvalued in 2026?

Based on GuruFocus' analysis, Enzymatica AB stock appears to be overvalued. The current stock price of €0.19 is trading 16.9% above its estimated GF Value™ of €0.16.

Key valuation signals for STU:EN9:

  • FCF Yield %: -6.90
  • GF Value™: €0.16 vs. price of €0.19 (16.9% above fair value)
  • GF Score™: 57/100 with 2 warning signs

No single metric tells the full story. See the STU:EN9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Enzymatica AB Business Description

Other Exchanges ENZY:SwedenEN9:Germany
Address Scheelevagen 19, Delta 5, Ideon Science Park, Lund, SWE, SE-223 70
Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period.
57GF Score

Get the complete analysis for STU:EN9

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.19
Price
€0.16
GF Value